IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Bergamo, Italy.
Unit of Nephrology and Dialysis, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
Sci Rep. 2018 Mar 20;8(1):4909. doi: 10.1038/s41598-018-23244-2.
Diabetic nephropathy (DN), the single strongest predictor of mortality in patients with type 2 diabetes, is characterized by initial glomerular hyperfiltration with subsequent progressive renal function loss with or without albuminuria, greatly accelerated with the onset of overt proteinuria. Experimental and clinical studies have convincingly shown that early interventions retard disease progression, while treatment if started late in the disease course seldom modifies the slope of GFR decline. Here we assessed whether the negligible renoprotection afforded by drugs in patients with proteinuric DN could be due to loss of glomerular structural integrity, explored by scanning electron microscopy (SEM). In diabetic patients with early renal disease, glomerular structural integrity was largely preserved. At variance SEM documented that in the late stage of proteinuric DN, glomerular structure was subverted with nearly complete loss of podocytes and lobular transformation of the glomerular basement membrane. In these circumstances one can reasonably imply that any form of treatment, albeit personalized, is unlikely to reach a given cellular or molecular target. These findings should persuade physicians to start the putative renoprotective therapy soon after the diagnosis of diabetes or in an early phase of the disease before structural integrity of the glomerular filter is irreversibly compromised.
糖尿病肾病 (DN) 是 2 型糖尿病患者死亡的单一最强预测因素,其特征是初始肾小球高滤过,随后进行性肾功能丧失,无论是否有白蛋白尿,伴有明显蛋白尿时会大大加速。实验和临床研究令人信服地表明,早期干预可延缓疾病进展,而在疾病过程后期开始治疗很少能改变肾小球滤过率下降的斜率。在这里,我们评估了蛋白尿性 DN 患者药物提供的微不足道的肾脏保护作用是否可能是由于肾小球结构完整性的丧失,这是通过扫描电子显微镜 (SEM) 来探索的。在早期肾脏疾病的糖尿病患者中,肾小球结构基本保持完整。相比之下,SEM 记录显示在蛋白尿性 DN 的晚期,肾小球结构被颠覆,足细胞几乎完全丧失,肾小球基底膜呈小叶状转化。在这种情况下,可以合理地推断,任何形式的治疗,即使是个体化治疗,也不太可能达到特定的细胞或分子靶点。这些发现应该促使医生在诊断糖尿病后或在肾小球滤过结构不可逆受损之前的疾病早期尽快开始潜在的肾脏保护治疗。